CPHI vs TXN · rev $4.1M vs P/E 52, rev $17.68B
China Pharma Holdings Inc (CPHI) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
CPHI currently screens at market cap $29.0M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the CPHI and TXN stock pages for the full models.
Not investment advice.